Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.41 USD | +4.23% | +3.05% | -54.02% |
03/04 | Stifel Cuts Price Target on Verve Therapeutics to $40 From $56, Maintains Buy Rating | MT |
02/04 | Sector Update: Health Care Stocks Slide Late Afternoon | MT |
Sales 2024 * | 13.01M 1.08B | Sales 2025 * | 10.02M 835M | Capitalization | 516M 43.02B |
---|---|---|---|---|---|
Net income 2024 * | -226M -18.84B | Net income 2025 * | -254M -21.17B | EV / Sales 2024 * | 5.86 x |
Net cash position 2024 * | 440M 36.67B | Net cash position 2025 * | 204M 17.02B | EV / Sales 2025 * | 31.1 x |
P/E ratio 2024 * |
-2.1
x | P/E ratio 2025 * |
-2.01
x | Employees | 255 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.38% |
Latest transcript on Verve Therapeutics, Inc.
1 day | +4.23% | ||
1 week | +3.05% | ||
Current month | +6.66% | ||
1 month | -22.96% | ||
3 months | -41.78% | ||
6 months | -53.98% | ||
Current year | -54.02% |
Managers | Title | Age | Since |
---|---|---|---|
Sekar Kathiresan
FOU | Founder | 52 | 01/18/01 |
Allison Dorval
DFI | Director of Finance/CFO | 48 | 29/21/29 |
Andrew Ashe
PSD | President | 57 | 01/18/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Burt Adelman
FOU | Founder | 71 | 01/18/01 |
Lonnel Coats
BRD | Director/Board Member | 58 | 08/22/08 |
Michael MacLean
BRD | Director/Board Member | 58 | 01/21/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.13% | 2 M€ | -25.75% | ||
3.54% | 1 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
03/24/03 | 6.41 | +4.23% | 1,394,637 |
02/24/02 | 6.15 | +2.50% | 949,617 |
01/24/01 | 6 | -0.17% | 1,764,706 |
30/24/30 | 6.01 | -3.99% | 1,022,039 |
29/24/29 | 6.26 | +1.62% | 933,216 |
Delayed Quote Nasdaq, May 04, 2024 at 02:00 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-54.02% | 516M | |
+25.69% | 48.09B | |
+46.90% | 40.62B | |
-3.46% | 40.43B | |
-6.20% | 28.36B | |
+9.17% | 24.89B | |
-20.42% | 19.01B | |
+28.07% | 12.09B | |
+0.17% | 11.88B | |
-1.24% | 11.8B |
- Stock Market
- Equities
- VERV Stock